CHECKMATE PHARMACEUTICALS IN (CMPI) Stock Cash Flow
NASDAQ:CMPI - Nasdaq - US1628181083 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.15M | -61.41M | -36.91M | -28.29M | -20.81M | |||
| Depreciation Amortization | N/A | 70.00K | N/A | N/A | N/A | |||
| Change In Working Capital | 6.65M | 1.47M | -3.51M | 1.51M | 240.00K | |||
| Other non cash items | 6.30M | 6.15M | 2.31M | -70.00K | 150.00K | |||
| OPERATING CASH FLOW | -50.08M | -53.72M | -38.11M | -26.85M | -20.42M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -840.00K | N/A | N/A | N/A | |||
| Other Investing Activity | 51.24M | 62.03M | -83.29M | N/A | N/A | |||
| INVESTING CASH FLOW | 50.40M | 61.19M | -83.29M | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 10.00M | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 150.00K | 150.27M | 18.98M | 10.93M | |||
| FINANCING CASH FLOW | N/A | 150.00K | 160.27M | 18.98M | 10.93M | |||
| CHANGE IN CASH | 350.00K | 7.62M | 38.87M | -7.87M | -9.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -50.08M | -53.72M | -38.11M | -26.85M | -20.42M | |||
| Capital Expenditure | N/A | -840.00K | N/A | N/A | N/A | |||
| FREE CASH FLOW | N/A | -54.56M | N/A | N/A | N/A | |||
All data in USD